Nataliia N. Gotmanova

Nataliia N. Gotmanova

Auto-generated profile, based on publicly available information

Nataliia N. Gotmanova

Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1,3 119991 Moscow, Russia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2025 in Biochimie
Verified
Journal Article
Closed access
NGNataliia N. Gotmanova
Nataliia N. Gotmanova
TBTatiana V. Bobik
Tatiana V. Bobik
VKViacheslav Kriachkov
Viacheslav Kriachkov
AEAlexander Ezhov
Alexander Ezhov
ABAnna V. Bacheva
Anna V. Bacheva

16 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
NGN.N. Gotmanova
N.N. Gotmanova
TBT.V. Bobik
T.V. Bobik
AEAlexander Ezhov
Alexander Ezhov
AVAnna Valyaeva
Anna Valyaeva
MZMaria Zvereva
Maria Zvereva
ABAnna V. Bacheva
Anna V. Bacheva
Polyglutamine diseases are incurable genetic neurodegenerative disorders characterized by the accumulation of extended polyglutamine fragments-containing mutant proteins, which are prone to the formation of poorly soluble aggregates. The adequate cellular model is crucial in uncovering the pathological mechanisms responsible for neurotoxicity in HD, screening for therapeutic molecules and elucidation of the molecular mechanisms impacted by particular compound. In the present study, genetic constructs based on the Sleeping Beauty system were created for the stable inducible expression of full-length normal and mutant huntingtin (Htt) in eukaryotic cells. These constructs were then employed to develop model neuronal cells using Neuro-2a cell line. The expression of Htt as well as the accumulation of Htt immunopositive intracellular aggregates (most characteristic features of HD) was demonstrated, and these aggregates showed colocalization with the proteasome. The activation of the proteasome, as well as changes in the expression of proteasome regulators, components of the autophagy system, and the neuronal proteases cathepsins B and D, reflect the versatility of cellular responses to the mutant pathological forms of Htt.